SOCS1 regulates type I/type II NKT cell balance by regulating IFNγ signaling

International Immunology

Volumn 23, Issue 3, 2011, Pages 165-176

  Hashimoto, Masayuki ^a,b   Hiwatashi, Kiyokazu ^b   Ichiyama, Kenji ^b   Morita, Rimpei ^b   Sekiya, Takashi ^b   Kimura, Akihiro ^b   Sugiyama, Yuki ^b   Sibata, Toshikatsu ^c   Kuroda, Kazumichi ^c   Takahashi, Reiko ^b   Yoshimura, Akihiko ^b,d  

^a KYUSHU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

IFN ; NKT; SOCS; Sulfatide; GalCer

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CONCANAVALIN A; GAMMA INTERFERON; SULFATIDE; SUPPRESSOR OF CYTOKINE SIGNALING 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN 14; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEPATITIS; HOMEOSTASIS; LIVER INJURY; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE;

EID: 79952613552     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq469     Document Type: Article

References (44)

1. Vaquero, J., Chung, C. and Blei, A. T. 2003. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann. Hepatol. 2:12.
2. Exley, M. A. and Koziel, M. J. 2004. To be or not to be NKT: natural killer T cells in the liver. Hepatology 40:1033.
3. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl Acad. Sci. USA. 97:5498.
4. Hong, F., Jaruga, B., Kim, W. H. et al. 2002. Opposing roles of STAT1 and STAT3 in Tcell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110:1503.
5. Kaneko, Y., Harada, M., Kawano, T. et al. 2000. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.
6. Rehermann, B. 2000. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J. Exp. Med. 191:1263.
7. Ryo, K., Kamogawa, Y., Ikeda, I. et al. 2000. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am. J. Gastroenterol. 95:2047.
8. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877.
9. Seino, K. and Taniguchi, M. 2005. Functionally distinct NKT cell subsets and subtypes. J. Exp. Med. 202:1623.
10. Diao, H., Kon, S., Iwabuchi, K. et al. 2004. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21:539.
11. Godfrey, D. I., Stankovic, S. and Baxter, A. G. Raising the NKTcell family. Nat. Immunol. 11:197.
12. Shamshiev, A., Donda, A., Prigozy, T. I. et al. 2000. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13:255.
13. Jahng, A., Maricic, I., Aguilera, C., Cardell, S., Halder, R. C. and Kumar, V. 2004. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199:947.
14. Zajonc, D. M., Maricic, I., Wu, D. et al. 2005. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202:1517.
15. Doisne, J. M., Bartholin, L., Yan, K. P. et al. 2009. iNKT cell development is orchestrated by different branches of TGF-beta signaling. J. Exp. Med. 206:1365.
16. Li, M. O., Sanjabi, S. and Flavell, R. A. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455.
17. Marie, J. C., Liggitt, D. and Rudensky, A. Y. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25:441.
18. Sakamoto, H., Yasukawa, H., Masuhara, M. et al. 1998. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92:1668.
19. Yasukawa, H., Misawa, H., Sakamoto, H. et al. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309.
20. Alexander, W. S., Starr, R., Fenner, J. E. et al. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597.
21. Marine, J. C., Topham, D. J., McKay, C. et al. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609.
22. Cornish, A. L., Davey, G. M., Metcalf, D. et al. 2003. Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis. J. Immunol. 170:878.
23. Ilangumaran, S., Ramanathan, S., Ning, T. et al. 2003. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes. Blood 102:4115.
24. Tanaka, K., Ichiyama, K., Hashimoto, M. et al. 2008. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J. Immunol. 180:3746.
25. Lu, L. F., Thai, T. H., Calado, D. P. et al. 2009. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30:80.
26. Naka, T., Tsutsui, H., Fujimoto, M. et al. 2001. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14:535.
27. Yoshida, T., Ogata, H., Kamio, M. et al. 2004. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J. Exp. Med. 199:1701.
28. Coquet, J. M., Kyparissoudis, K., Pellicci, D. G. et al. 2007. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178:2827.
29. Bendelac, A. 1995. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091.
30. Chun, T., Page, M. J., Gapin, L. et al. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 197:907.
31. Watarai, H., Rybouchkin, A., Hongo, N. et al. Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Valpha14-Jalpha18 TCRalpha gene. Blood 115:230.
32. Nunez-Cruz, S., Yeo, W. C., Rothman, J. et al. 2008. Differential requirement for the SAP-Fyn interaction during NK T cell development and function. J. Immunol. 181:2311.
33. Nakaya, M., Hashimoto, M., Nakagawa, R. et al. 2009. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis. J. Immunol. 183:7047.
34. Kinjyo, I., Inoue, H., Hamano, S. et al. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203:1021.
35. Lindh, E., Rosmaraki, E., Berg, L. et al. AIRE deficiency leads to impaired iNKT cell development. J. Autoimmun. 34:66.
36. Yang, J. Q., Saxena, V., Xu, H., Van Kaer, L., Wang, C. R. and Singh, R. R. 2003. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J. Immunol. 171:4439.
37. Gombert, J. M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C. and Bach, J. F. 1996. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989.
38. Yoshimoto, T., Bendelac, A., Hu-Li, J. and Paul, W. E. 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl Acad. Sci. USA. 92:11931.
39. Van Kaer, L. 2004. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol. Cell Biol. 82:315.
40. Cornish, A. L., Chong, M. M., Davey, G. M. et al. 2003. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278:22755.
41. Prussin, C. and Foster, B. 1997. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159:5862.
42. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. and Bendelac, A. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895.
43. Norris, S., Doherty, D. G., Collins, C. et al. 1999. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum. Immunol. 60:20.
44. Gadola, S. D., Silk, J. D., Jeans, A. et al. 2006. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203:2293.